The multiple myeloma drug Blenrep is being removed from the U.S. market after the fast-tracked cancer drug failed to perform in a recent clinical trial.
Plaintiffs involved in Zantac litigation have submitted new evidence from a recently published study which links Zantac use to four different types of cancer.
State courts are being flooded with thousands of lawsuits over Zantac cancers which have not been included in the consolidated federal Multidistrict Litigation.
Daubert hearings for expert witnesses slated for Zantac cancer trials will begin on September 21.
A Zantac lawsuit was settled by generic drug makers, and dropped against GSK just days before trial was set to begin in an Illinois state court.
Ahead of the first Zantac lawsuit trials, slated to begin next year, investors sold off Sanofi, GlaxoSmithKline and Pfizer stocks, anticipating massive court losses and costs.
Makers of brand-name drugs want a federal judge to exclude expert witnesses for plaintiffs, seeking a summary judgment to have Zantac cancer risk lawsuits dismissed before they can make it…
A federal judge has scheduled hearings over Zantac cancer lawsuit Daubert motions for September.
A federal judge is calling on parties in Zantac cancer litigation to finalize a registry of potential plaintiffs and their information as the lawsuits enter the latter stages of pretrial…
Plaintiffs have identified five types of cancer which will be pursued in federal Zantac lawsuits, including bladder cancer, esophageal cancer, gastric cancer, liver cancer and pancreatic cancer.
